Russian pharma strategy cheers domestic firms but is criticised by state purse-keeper
This article was originally published in RAJ Devices
The Russian ministry for economy and energy has finalised the draft: “Strategy for the development of the pharmaceutical industry in the Russian Federation until 2020”, on which it has been working since the beginning of this year. The draft – presently being discussed by the country’s cabinet – has already been criticised by the ministry of finance, raising fears among domestic drug manufacturers that the Russian pharmaceutical industry will not see any significant results from the document’s implementation.
You may also be interested in...
With a view to strengthening its integrated approach towards animal health, the European Food Safety Authority (EFSA) has set itself six goals that it will pursue in the near future. The inspiration for the recent authority paper in which the goals have been set down, is the current EU Animal Health Strategy for 2007-2013. EFSA believes that it is uniquely positioned to adopt an integrated approach to animal health, taking into account the relationship between animal welfare, animal diseases and food safety – areas that are all within the authority’s remit.
The Danish Medicines Agency (Lægemiddelstryrelsen) has found itself in the uncomfortable position of having to warn the public against two wholly misleading chain emails about restrictions on the sale of dietary supplements.
The latest Flash Eurobarometer poll has shown that EU citizens are seriously concerned about the prospect of using animal cloning for food production. The survey was carried out following a request by the European Commission to assess citizens' attitudes towards animal cloning in light of the opinions on the issue published this year by the European Food Safety Authority (EFSA) and the Commission’s European Group of Ethics on science and new technology (EGE).